These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
84 related items for PubMed ID: 3110673
21. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism. Rostaing L, Moreau-Gaudry X, Baron E, Cisterne JM, Monroziès-Bernadet P, Durand D. Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792 [Abstract] [Full Text] [Related]
22. Long-term outcome following total parathyroidectomy in patients with end-stage renal disease. Kaye M, Rosenthall L, Hill RO, Tabah RJ. Clin Nephrol; 1993 Apr; 39(4):192-7. PubMed ID: 8491048 [Abstract] [Full Text] [Related]
23. Risk of orally administered aluminium hydroxide and results of withdrawal. Bournerias F, Monnier N, Reveillaud RJ. Proc Eur Dial Transplant Assoc; 1983 Apr; 20():207-12. PubMed ID: 6657657 [Abstract] [Full Text] [Related]
24. Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of optimal hemopurification and parathyroidectomy. Hida M, Shimbo T, Takeda M, Saito H, Satoh T, Tajima T. Tokai J Exp Clin Med; 1983 Jul; 8(3):229-34. PubMed ID: 6670109 [Abstract] [Full Text] [Related]
25. Intraoperative parathyroid hormone monitoring during parathyroidectomy for hyperparathyroidism in waiting list and kidney transplant patients. Gioviale MC, Gambino G, Maione C, Luna E, Calderone F, Di Bona A, Buscemi G, Romano M, Lo Monte AI. Transplant Proc; 2006 May; 38(4):1003-5. PubMed ID: 16757245 [Abstract] [Full Text] [Related]
26. [Progressive myoclonic encephalopathy in dialysis patients. The role of the water used for haemodialysis (author's transl)]. Cartier F, Allain P, Gary J, Chatel M, Menault F, Pecker S. Nouv Presse Med; 1978 Jan 14; 7(2):97-102. PubMed ID: 652514 [Abstract] [Full Text] [Related]
27. Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy. Ugur O, Bozkurt MF, Hamaloglu E, Sokmensuer C, Etikan I, Ugur Y, Sayek I, Gulec SA. Arch Surg; 2004 Nov 14; 139(11):1175-9. PubMed ID: 15545562 [Abstract] [Full Text] [Related]
28. Female hemodialysis patients have an increased risk of nodular hyperplasia of parathyroid glands. Lomonte C, Cazzato F, Casucci F, Chimienti D, Bruno A, Cocola S, Verrelli EA, Basile C. J Nephrol; 2005 Nov 14; 18(1):92-5. PubMed ID: 15772929 [Abstract] [Full Text] [Related]
29. The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy. Milne FJ, Sharf B, Bell P, Meyers AM. Clin Nephrol; 1983 Oct 14; 20(4):202-7. PubMed ID: 6641027 [Abstract] [Full Text] [Related]
30. Aluminium-induced, reversible microcytic anemia in chronic renal failure: clinical and experimental studies. Touam M, Martinez F, Lacour B, Bourdon R, Zingraff J, Di Giulio S, Drüeke T. Clin Nephrol; 1983 Jun 14; 19(6):295-8. PubMed ID: 6872366 [Abstract] [Full Text] [Related]
31. Aluminium overload of parathyroid glands in haemodialysed patients with hyperparathyroidism: effect on bone remodelling. Berland Y, Charbit M, Henry JF, Toga M, Cano JP, Olmer M. Nephrol Dial Transplant; 1988 Jun 14; 3(4):417-22. PubMed ID: 3140127 [Abstract] [Full Text] [Related]
32. Aluminium intoxication in renal disease. Kerr DN, Ward MK, Ellis HA, Simpson W, Parkinson IS. Ciba Found Symp; 1992 Jun 14; 169():123-35; discussion 135-41. PubMed ID: 1490419 [Abstract] [Full Text] [Related]
33. [Progressive myoclonic encephalopathy in dialysis patients. Clinical, electroencephalographic and neuropathological study. Pathogenetic discussion]. Sabouraud O, Chatel M, Menault F, Dien Peron J, Cartier F, Garre M, Gary J, Pecker S. Rev Neurol (Paris); 1978 Oct 14; 134(10):575-600. PubMed ID: 107555 [Abstract] [Full Text] [Related]
34. Clinical and histological results of long-term management of aluminium overloading in uraemic patients with desferrioxamine. Canavese C, Pacitti A, Segoloni G, Thea A, D'Amicone M, Stratta P, Rossi P, Sabbioni E, Pietra R, Constantini S. J Trace Elem Electrolytes Health Dis; 1989 Mar 14; 3(1):17-23. PubMed ID: 2535315 [Abstract] [Full Text] [Related]
35. [Dialysis encephalopathy and aluminum poisoning? Correlated clinical, pathologic-anatomic and spectrometric findings]. Weiller C, Spiegel P, Van de Vijver F. Nervenarzt; 1986 Aug 14; 57(8):461-4. PubMed ID: 3092120 [Abstract] [Full Text] [Related]
36. Bone aluminum intoxication: an unpreventable sequel of parathyroidectomy? Pizzarelli F, Giordano R, Ballanti P, Costantini S, Mocetti P, Maggiore Q. Nephron; 1988 Aug 14; 48(3):250-1. PubMed ID: 3352856 [No Abstract] [Full Text] [Related]
37. The case against aluminum affecting parathyroid function. Alfrey AC. Am J Kidney Dis; 1985 Nov 14; 6(5):309-12. PubMed ID: 4061453 [Abstract] [Full Text] [Related]
38. Influence of aluminium overload on the course of post-transplant parathyroid function. Garay G, Grosso S, Douthat W, Fernández Martín JL, Cannata J, Massari PU. Nephrol Dial Transplant; 1996 Nov 14; 11 Suppl 3():65-8. PubMed ID: 8840318 [Abstract] [Full Text] [Related]
39. [Reversible dialytic encephalopathy after interruption of aluminium intake. 6 cases (author's transl)]. Buge A, Poisson M, Masson S, Bleibel JM, Mashaly R, Jaudon MC, Lafforgue B, Lebkiri B, Raymond P. Nouv Presse Med; 1979 Sep 10; 8(34):2729-33. PubMed ID: 493078 [Abstract] [Full Text] [Related]
40. [Aluminum poisoning in renal dialysis patients: bone histology. Value of quantitative bone biopsy]. Charhon SA, Chapuy MC, Traeger J, Meunier PJ. Presse Med; 1984 Jun 02; 13(23):1431-4. PubMed ID: 6233588 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]